9 October 2013
RIGHTMOVE PLC
DIRECTOR/PDMR SHAREHOLDING
Rightmove plc (the "Company") has received the following notifications today
from Nick McKittrick, Chief Executive Officer and Peter Brooks-Johnson, Chief
Operating Officer:
Nick McKittrick confirmed that on 9 October 2013 he exercised his right to acquire:
* 200,000 unapproved executive share options at an exercise price of 335p
* 75,000 unapproved executive share options at an exercise price of 522p
* 6,000 approved executive share options at an exercise price of 410p
He subsequently sold the ordinary shares received of 1p each in the Company
("ordinary shares") at an average price of 2364.1341p.
Nick McKittrick also confirmed that, today, he exercised his right to acquire
29,199 deferred shares awarded at nil cost in March 2011 in respect of his 2010
financial year bonus and subsequently sold all the ordinary shares received at
an average price of 2364.1341p.
The number of ordinary shares sold in total represented 0.26% of the ordinary
shares in issue (less shares held in treasury) prior to such sale.
Following these transactions, the beneficial shareholding of Nick McKittrick is
130,350 ordinary shares representing 0.13% of the ordinary shares in issue
(excluding shares held in treasury). Nick McKittrick also holds executive and
Sharesave options over 394,614 ordinary shares, deferred share awards over
35,367 ordinary shares and 120,871 performance shares.
Peter Brooks-Johnson confirmed that on 9 October 2013 he exercised his right to
acquire 18,393 deferred shares awarded at nil cost in March 2011 in respect of
his 2010 financial year bonus and subsequently sold all the ordinary shares
received at an average price of 2364.1341p.
The number of ordinary shares sold represented 0.02% of the ordinary shares in
issue (less shares held in treasury) prior to such sale.
Following these transactions, the beneficial shareholding of Peter
Brooks-Johnson is 15,016 ordinary shares representing 0.01% of the ordinary
shares in issue (excluding shares held in treasury). Peter Brooks-Johnson also
holds executive and Sharesave options over 269,972 ordinary shares, deferred
share awards over 25,803 ordinary shares and 73,842 performance shares.
This announcement is made under the UKLA's Disclosure and Transparency Rule
3.1.4R.
Ends
Name and contact number for queries:
Jenny Warburton 0207 087 0739
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.